About

Intercontinental Biotech, Inc. was registered under company Id C17922-1997 and Nevada Business Id NV19971248744. This company type is Domestic Corporation. This business was created twenty-six years, eight months and thirty days years ago - on 1997-08-21. Current company status is Permanently Revoked.

Affordable Business Services, Inc. is the current agent of this company. This agent office address is 1055 E. Flamingo Rd. #1009A, Las Vegas, 89119 NV. Intercontinental Biotech, Inc. home state is NV.

There are 6 officers and directors in this company. Jeong Soon Lee with treasurer title, Jeong Soon Lee with treasurer title, Joseph Saraceno with president title, Joseph Saracent with president title, Joseph Saracent with secretary title, Joseph Saracent with secretary title.

Get Data On Smartphone

Scan QR Code below, to get information about Intercontinental Biotech, Inc. on your smartphone. You will need QR Code reader app.

Company Agent

Name Affordable Business Services, Inc.
Status -
Jurisdiction -
Type Noncommercial Registered Agent
Address 1055 E. Flamingo Rd. #1009A
City Las Vegas
State NV
ZIP 89119
Mailing State -

Agent Address On Map

Main Information

Company Name Intercontinental Biotech, Inc.
Company Id C17922-1997
NV Business Id NV19971248744
Company Type Domestic Corporation
Managed By
NV Business Id NV19971248744
Home State Nevada

Officers

Title Name Address
Treasurer Jeong Soon Lee 2700 State St., Las Vegas, 89119, Nv
Treasurer Jeong Soon Lee 2700 State St., #17, Las Vegas, 89119, Nv
President Joseph Saraceno 2700 State St., Las Vegas, 89119, Nv
President Joseph Saracent 2700 State St., #17, Las Vegas, 89119, Nv
Secretary Joseph Saracent 2700 State St., #17, Las Vegas, 89119, Nv
Secretary Joseph Saracent 2700 State St., Las Vegas, 89119, Nv

Status Information

Company Status Permanently Revoked
Incorporation Date 08/21/1997
List of Officers Due 08/31/1999

Companies Close To Intercontinental Biotech, Inc.

Similar Companies By Name Intercontinental Biotech, Inc.

Reviews

Be the first to comment

0 comments